The impact of DXA findings on general practitioners’ decision regarding first-line oral bisphosphonates in postmenopausal osteoporosis—data from French General Practice (the IMOGENE study)

Related documents

• Cubosomal nanoparticles of lycopene as a novel platform for enhancement in antioxidant and anticancer properties with a molecular docking study#1053258
• Development and validation of a novel panel of CSF biomarkers for Alzheimer’s disease#1053259
• Ecogeomorphic feedbacks influence elevation change across microtidal wetland settings of coastal Louisiana#1053260
• Type one protein phosphatases (TOPPs) catalyze EIN2 dephosphorylation to regulate ethylene signaling in Arabidopsis#1053261
• E7 11-19 placement and orientation dictate CD8 + T cell response in structurally defined spherical nucleic acid vaccines#1053262